Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134a in Chinese patients with asthma uncontrolled on medium doses of ICS+LABA.
Epistemonikos ID: 4993a041378ed5dbc36d8ec8388b27db2fdb1364
First added on: Apr 24, 2026